More recently, the MISTIE II (Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase II) trial showed a strong trend toward clinical benefit in patients with ICH treated with MIS followed by catheter drainage with daily recombinant tissue plasminogen activator (tPA) irrigation.
← all excerpts
Analysis of three surgical treatments for spontaneous supratentorial intracerebral hemorrhage.
1
—
—